Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-16

Sino-European Project on SARS Diagnostics and Antivirals

Objective

Combatting and eventually eradicating the new coronavirus causing Severe Acute Respiratory Syndrome (SARS) requires specific and efficient antiviral drugs and improved diagnostics. The Sino-European Project on SARS Diagnostics and Antivirals (SEPSDA) is an integrated project that applies modern biotechnical technology for the generation of improved diagnostics and of lead compounds for antiviral drugs. SEPSDA brings together leading SARS researchers from Germany, Denmark, Poland, and China, who together have an excellent publication record on the molecular biology of SARS coronavirus (SARS-CoV). Several of the existing anti-SARS drug leads as well as the first antibody-based diagnostic kit were created by members of SEPSDA. Participation of four leading laboratories in China brings SEPSDA in the unique position of having access to samples from Chinese patients at various stages of disease. Serological studies will lead to improved SARS diagnostics. Analysis of the genome and the proteome of SARS coronavirus by sequencing and advanced bioinformatics will further determine the genetic variability of the virus isolates and identify new possible targets for therapeutic intervention, both at the RNA and the protein level. SEPSDA aims at determining the three-dimensional structures of all soluble SARS-CoV proteins or domains thereof. This structural genomics approach will provide the basis for the virtual screening of large compound databases, including those containing Chinese traditional medicines, for molecules potentially interfering with the function of the viral proteins or their interaction partners in the host cell. Candidate inhibitors will be tested in cell culture and improved by synthetic chemistry. After patenting, the lead compounds will be offered to an industrial platform on SARS, yet to be created, which should form an interface between SEPSDA and the pharmaceutical industry.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2003-SSP-2-SARS
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

STREP - Specific Targeted Research Project

Coordinator

UNIVERSITY OF LUEBECK
EU contribution
No data
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (7)

My booklet 0 0